These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1749398)

  • 21. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
    Park KS; Kang KC; Kim JH; Adams DJ; Johng TN; Paik YK
    J Antimicrob Chemother; 1999 May; 43(5):667-74. PubMed ID: 10382888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro effect of itraconazole against various species of Candida].
    Bastide M; Mallie M; Jouvert S; Montes B; Bastide JM
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
    Odds FC; Cheesman SL; Abbott AB
    Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of Candida cell virulence by anticancer drugs and irradiation.
    Ueta E; Tanida T; Yoneda K; Yamamoto T; Osaki T
    Oral Microbiol Immunol; 2001 Aug; 16(4):243-9. PubMed ID: 11442850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole.
    Eshwika A; Coyle B; Devereux M; McCann M; Kavanagh K
    Biometals; 2004 Aug; 17(4):415-22. PubMed ID: 15259362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal drugs affect adherence of Candida albicans to acrylic surfaces by changing the zeta-potential of fungal cells.
    Miyake Y; Tsunoda T; Minagi S; Akagawa Y; Tsuru H; Suginaka H
    FEMS Microbiol Lett; 1990 Jun; 57(3):211-4. PubMed ID: 2210332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
    Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5-fluorocytosine and miconazole on Candida albicans.
    Scalarone GM; Mikami Y; Kurita N; Ichihara Y; Yazawa K; Miyaji M
    Mycoses; 1991; 34(7-8):297-302. PubMed ID: 1803230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of two polyene and two imidazole antimicrobics on Candida albicans in human fibrin clots.
    Smith BM; Hoeprich PD; Huston AC; Schaffner CP; Franti CE
    J Lab Clin Med; 1983 Jul; 102(1):126-32. PubMed ID: 6304213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM; Law EJ; Belcher KE; Spencer SA
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
    Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
    Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis.
    Beggs WH; LaSota IR; Hughes CE
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):413-4. PubMed ID: 3137047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations.
    De Logu A; Fadda AM; Anchisi C; Maccioni AM; Sinico C; Schivo ML; Alhaique F
    J Antimicrob Chemother; 1997 Dec; 40(6):889-93. PubMed ID: 9462444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.
    Brajtburg J; Kobayashi D; Medoff G; Kobayashi GS
    J Infect Dis; 1982 Aug; 146(2):138-46. PubMed ID: 6286784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B-resistant Candida albicans.
    Hopfer RL
    J Infect Dis; 1992 Nov; 166(5):1196-8. PubMed ID: 1402037
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of miconazole on the ultrastructure of Candida albicans.
    de Nollin S; Borgers M
    Proc R Soc Med; 1977; 70 Suppl 1(Suppl 1):9-12. PubMed ID: 233843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.